Literature DB >> 17031532

Interrogating the druggable genome with structural informatics.

Kevin Hambly1, Joseph Danzer, Steven Muskal, Derek A Debe.   

Abstract

Structural genomics projects are producing protein structure data at an unprecedented rate. In this paper, we present the Target Informatics Platform (TIP), a novel structural informatics approach for amplifying the rapidly expanding body of experimental protein structure information to enhance the discovery and optimization of small molecule protein modulators on a genomic scale. In TIP, existing experimental structure information is augmented using a homology modeling approach, and binding sites across multiple target families are compared using a clique detection algorithm. We report here a detailed analysis of the structural coverage for the set of druggable human targets, highlighting drug target families where the level of structural knowledge is currently quite high, as well as those areas where structural knowledge is sparse. Furthermore, we demonstrate the utility of TIP's intra- and inter-family binding site similarity analysis using a series of retrospective case studies. Our analysis underscores the utility of a structural informatics infrastructure for extracting drug discovery-relevant information from structural data, aiding researchers in the identification of lead discovery and optimization opportunities as well as potential "off-target" liabilities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031532     DOI: 10.1007/s11030-006-9035-3

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  27 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  A new method to detect related function among proteins independent of sequence and fold homology.

Authors:  Stefan Schmitt; Daniel Kuhn; Gerhard Klebe
Journal:  J Mol Biol       Date:  2002-10-18       Impact factor: 5.469

Review 3.  Molecular modelling of drug targets: the past, the present and the future.

Authors:  Svein G Dahl; Ingebrigt Sylte
Journal:  Basic Clin Pharmacol Toxicol       Date:  2005-03       Impact factor: 4.080

Review 4.  Design strategies for protein kinase inhibitors.

Authors:  Keykavous Parang; Gongqin Sun
Journal:  Curr Opin Drug Discov Devel       Date:  2004-09

Review 5.  Surprising similarities in structure comparison.

Authors:  J F Gibrat; T Madej; S H Bryant
Journal:  Curr Opin Struct Biol       Date:  1996-06       Impact factor: 6.809

6.  The FSSP database of structurally aligned protein fold families.

Authors:  L Holm; C Sander
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

7.  Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen.

Authors:  Antonietta Bernardo; Maria Antonietta Ajmone-Cat; Laura Gasparini; Ennio Ongini; Luisa Minghetti
Journal:  J Neurochem       Date:  2005-02       Impact factor: 5.372

8.  Estrogen sulfotransferase and sulfatase: Roles in the regulation of estrogen activity in human uterine endometrial carcinomas.

Authors:  Kyoko Tanaka; Kaneyuki Kubushiro; Yuriko Iwamori; Yuzuru Okairi; Kazushige Kiguchi; Isamu Ishiwata; Katsumi Tsukazaki; Shiro Nozawa; Masao Iwamori
Journal:  Cancer Sci       Date:  2003-10       Impact factor: 6.716

9.  Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors.

Authors:  Marjolein M G M Thunnissen; Björn Andersson; Bengt Samuelsson; Chi-Huey Wong; Jesper Z Haeggström
Journal:  FASEB J       Date:  2002-08-07       Impact factor: 5.191

10.  Conception and pharmacodynamic profile of drospirenone.

Authors:  Walter Elger; Sybille Beier; Kunhard Pollow; Robert Garfield; Shao Qing Shi; Alexander Hillisch
Journal:  Steroids       Date:  2003-11       Impact factor: 2.668

View more
  12 in total

Review 1.  Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.

Authors:  Qin Nie; Xiao-guang Du; Mei-yu Geng
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

2.  Identification of family-specific residue packing motifs and their use for structure-based protein function prediction: I. Method development.

Authors:  Deepak Bandyopadhyay; Jun Huan; Jan Prins; Jack Snoeyink; Wei Wang; Alexander Tropsha
Journal:  J Comput Aided Mol Des       Date:  2009-06-20       Impact factor: 3.686

3.  Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening.

Authors:  Stephan C Schürer; Steven J Brown; Pedro J Gonzalez-Cabrera; Marie-Therese Schaeffer; Jacqueline Chapman; Euijung Jo; Peter Chase; Tim Spicer; Peter Hodder; Hugh Rosen
Journal:  ACS Chem Biol       Date:  2008-07-01       Impact factor: 5.100

4.  Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design.

Authors:  Dusica Vidović; Stephan C Schürer
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

5.  Which compound to select in lead optimization? Prospectively validated proteochemometric models guide preclinical development.

Authors:  Gerard J P van Westen; Jörg K Wegner; Peggy Geluykens; Leen Kwanten; Inge Vereycken; Anik Peeters; Adriaan P Ijzerman; Herman W T van Vlijmen; Andreas Bender
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

6.  UniDrug-target: a computational tool to identify unique drug targets in pathogenic bacteria.

Authors:  Sree Krishna Chanumolu; Chittaranjan Rout; Rajinder S Chauhan
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

Review 7.  Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets.

Authors:  Uzma Saqib; Tanya T Kelley; Siva K Panguluri; Dongfang Liu; Rajkumar Savai; Mirza S Baig; Stephan C Schürer
Journal:  Front Pharmacol       Date:  2018-10-24       Impact factor: 5.810

8.  Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway.

Authors:  Steven M Muskal; Joe Sliman; John Kokai-Kun; Mark Pimentel; Vince Wacher; Klaus Gottlieb
Journal:  F1000Res       Date:  2016-04-08

Review 9.  Peptides as Potential Therapeutics for Alzheimer's Disease.

Authors:  Samo Ribarič
Journal:  Molecules       Date:  2018-01-30       Impact factor: 4.411

Review 10.  Editorial focus: understanding off-target effects as the key to successful RNAi therapy.

Authors:  Rafal Bartoszewski; Aleksander F Sikorski
Journal:  Cell Mol Biol Lett       Date:  2019-12-09       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.